Message errors from NHS Cancer Screening led to the death of the mother

The family of a mother who died of cervical cancer after she was wrongly communicated twice that she achieved negative results was not announced.

The misfiring by Louise Gleadell’s cervix -Screering results was recorded by University Hospitals of the Leicester NHS Trust after her death at the age of 38 in March 2018.

An internal review in 2017 showed that the four -year samples were not good enough to achieve reliable results, but neither Ms. Gleadell – a mother for three boys – and her relatives were told about the “inadequate” samples while she was still alive.

Your family has now received an unknown pay, with trust apologized for his mistakes that had “devastating consequences”.

Ms. Gleadell from Cossington in Leicestershire was diagnosed with cervical cancer two years before her death. At this stage it was too late to be operated on.

Two neck screening tests carried out in 2008 and 2012 were given to her as negative.

This meant that over a period of four years she had given the wrong calming about her health when she learned cervical cancer, and the opportunity to treat pre -cancer -like cells.

In fact, after the internal review of the trust in 2017, it was found that both samples were “insufficient”, and it was found that Ms. Gleadell should have been invited to have repeated the tests.

Ms. Gleadell’s sisters, Laura and Clare Gleadell, say that their grief was reinforced by knowing that her sister’s death was avoidable.

Laura, 43, said: “Her death was avoidable and that is really difficult for us.

“It would not have developed into cancer if it had been called back in 2008 or 2012.

“If she had treated to cell anomalies before cancer, she would not have died.”

Clare emphasized that the test results were reported incorrectly and that her death was “incredibly difficult to live”.

The 40-year-old added: “It is something that we probably think of most days if not every day.”

Louise described the sisters as her three boys, who were two, 11 and 13 years old when they lost their mother.

“Family for them was everything,” they said.

Louise felt uncomfortable at the end of 2015 and had pain, abnormal bleeding and unexpected weight loss.

By February of the following year, she was so concerned about her health that she paid privately for an ultrasound scan.

The results led to further investigations, and a biopsy provided by the NHS led to a diagnosis of cervical cancer in March.

Louise was subjected to chemotherapy, radiation therapy and brachy therapy, which is an internal radiation treatment. At first she recovered well, but a few months later she developed new symptoms.

Towards the end of 2016, the doctors told her that the disease was terminal.

With donations, Louise traveled abroad for immunotherapy in Germany, but ultimately it did not stop the fatal spread of cancer. She died in Loros Hospice in Leicester.

The NHS looks back routinely and checks the test results again after any cervical cancer was diagnosed with someone.

After the family had created lawyers to investigate the case, the family found that the NHS trust in summer 2017 knew the incorrect report of the results – before Louise died.

It is not clear why Louise was not told about it.

Gemma Lewis of Moosa duke lawyers of the clinical negligent lawyer who unveiled the situation and said that the trust should have said Louise.

“I don’t think the family has to find out of mine,” she added.

“Someone with a medical background would have explained things that could answer all follow-up questions.

“It should not require a legal examination – that you may not have decided to uncover the truth.”

Richard Mitchell, Managing Director of the Trust, said: “I’m very sorry that mistakes were made how we communicated Louise and with the devastating consequences.

“Errors such as the Louise care are rare, and since 2019 significant improvements to the neck screening -screening have been made as a human papillomavirus (HPV) tests were introduced at the national level.

“After an examination of the care of Louise, we have strengthened our processes for the parts of the results of quality tests in the Hals -Screening to ensure prompt and open communication.

“We understand that Louise’s family still has questions and we turned to meet.”

After the excuse of the trust, Louise’s sisters emphasized that they would encourage all women to work for one Neck screening.

The NHS says that Cervical Screening checks a sample of cells from their cervix over certain types of human papillomavirus (HPV).

These types of HPV can cause abnormal changes in the cells in their cervix and are called “high risk” types of HPV.

If high risk types of HPV are found during the screening, the cell sample is also checked for abnormal cell changes.

If abnormal cells are found, they can be treated so that they have no chance of transforming into cervical cancer.

Louise’s sisters added that they intended to take over the trust for a meeting.

Clare said: “We have unanswered questions – just how and why was Louise false information after her cuts and why, when the mistakes were emphasized after their diagnosis, the family was not told?

“The most difficult part is to see Louise’s three boys without her mother. It is heartbreaking – the effects of walking was terrible.”